spacer
home > ebr > spring 2019 > connecting erp and rim data
PUBLICATIONS
European Biopharmaceutical Review

Connecting ERP and RIM Data

The more readily different parts of life sciences organisations can share good quality data, the greater the benefits for everyone concerned. However, all of this relies on an ability to harness the right data at the right time as a useful asset. As long as data is entered in different ways into different systems and in functional siloes, the scope for improving productivity and efficiency and delivering strategic business benefits will be limited. What other options are available and what is involved in a ‘master data management’ approach?

Improved data exchange was the subject of a recent roundtable debate among experienced industry experts. On the panel were Steve Gens, managing partner at Gens & Associates, Kelly Hnat, Principal at K2 Consulting, Jesper Kihl, Vice President for Global Regulatory Affairs at LEO Pharm, Jan Vindberg-Larsen, Senior Director and Head of Global Regulatory Affairs at Lundbeck, Erick Gaussens PhD, Chief Scientific Officer at ProductLife Group (PLG), Catherine Gambert, Senior Consultant for Regulatory Affairs and Regulatory Information at PLG, and Loetitia Jabri, Regulatory and Pharmaceutical Platforms Associate Director at PLG.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Erick Gaussens PhD is co-founder, Principal Consultant, and Chief Scientific Officer at ProductLife Group, providing deep insights into risk management and regulatory sciences in the life sciences industry, as well as expertise in cognitive science.
spacer
Eric Gaussens PhD
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PPMA Group Industry Awards 2019

PPMA Group is today issuing a ‘Final Call for Entries’ to the 2019 PPMA Group Industry Awards. All companies within the packaging and processing sector are invited to submit their FREE submission by the deadline of 17 July 2019.
More info >>

White Papers

Analysis of Biopharmaceuticals to Conform to ICHQ6B

RSSL

Worldwide, the pharmaceuticals market is anticipated to grow from more than USD 782 billion in 2011 to approach a value of just over USD 971 billion by the end of 2016, registering a CAGR of over 24%. In 2010 the average medicines expenditure per person within the UK was £271, and this is expected to increase with the ageing population. A significant and increasing proportion of these sales are protein-based biotherapeutics or biomolecules. Currently, these account for 19% of the total market, and are growing at twice the rate of traditional small molecule pharmaceuticals. It is predicted that close to 50% of the top 100 pharmaceutical products will be biomolecules by 2016. By far the largest segment of the biopharmaceutical market is the monoclonal antibody (MAb) with an estimated share of 25.6%, which corresponds to USD 51.1 billion.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement